Hospital
Oak Hill Hospital Corporation
Oak Hill Hospital Corporation was paid $18.77M by Medicaid between Jan 2018 and Jul 2023, across 144 billing codes. Its largest line is 74176, Computed tomography, abdomen and pelvis; without contrast material — 9.0% of everything it billed.
33Billing provider infoOAK HILL HOSPITAL CORPORATION
OAK HILL, WV 25901
OAK HILL, WV 25901
33aNPI1598736159assigned 01/31/2006
33bProvider typeCritical Access Hospital
28Total paid$18.77M
24GClaims262,871
24DCodes billed144
24AFirst – last monthJan 2018 – Jul 2023
Compared with peers
Next to other Critical Access Hospital providers in West Virginia
Rank by total paid#3 of 24
Median peer was paid$3.57M
This provider vs. median5.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,280 | $4.27M | |
| 2019 | 40,747 | $3.28M | |
| 2020 | 56,936 | $4.76M | |
| 2021 | 52,305 | $3.12M | |
| 2022 | 47,881 | $2.52M | |
| 2023 | 14,722 | $822K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 9.0% | 3,030 | 2,685 | $1.69M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.6% | 12,251 | 10,922 | $1.61M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.8% | 7,804 | 6,792 | $1.47M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.9% | 4,207 | 3,568 | $1.10M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 5.4% | 1,409 | 1,244 | $1.01M |
| 80053 | Comprehensive metabolic panel | 4.5% | 16,661 | 12,773 | $851K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.5% | 2,641 | 2,381 | $843K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.5% | 1,193 | 1,019 | $650K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 17,589 | 13,672 | $526K |
| J3490 | Unclassified drugs | 2.7% | 18,027 | 6,821 | $499K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.3% | 8,384 | 6,577 | $430K |
| 36415 | Collection of venous blood by venipuncture | 2.1% | 19,975 | 14,760 | $397K |
132 more codes
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 2.1% | 414 | $394K |
| 84484 | 1.8% | 7,214 | $343K | |
| 71045 | Radiologic examination, chest; single view | 1.8% | 7,246 | $329K |
| 83880 | 1.5% | 2,718 | $278K | |
| 81001 | 1.4% | 8,533 | $270K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.4% | 338 | $259K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 2,138 | $243K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 1,611 | $194K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,333 | $170K |
| 83690 | <1% | 4,980 | $169K | |
| 71250 | <1% | 417 | $169K | |
| 87040 | <1% | 4,976 | $164K | |
| 83735 | <1% | 4,265 | $158K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,350 | $156K |
| 82553 | <1% | 2,265 | $154K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,184 | $145K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 188 | $137K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,469 | $136K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,298 | $131K |
| 83605 | <1% | 3,639 | $127K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,493 | $127K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,445 | $127K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 186 | $126K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,617 | $119K |
| 85027 | <1% | 3,562 | $114K | |
| 82150 | <1% | 2,605 | $113K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,594 | $113K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 141 | $109K |
| 85379 | <1% | 1,710 | $108K | |
| 82550 | <1% | 2,651 | $104K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,123 | $102K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,510 | $102K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 291 | $102K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,866 | $101K |
| 85730 | <1% | 1,766 | $99K | |
| 86710 | <1% | 1,295 | $92K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 651 | $92K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 331 | $84K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,471 | $69K |
| 85610 | <1% | 2,800 | $64K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,900 | $63K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,541 | $57K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,148 | $56K |
| 84703 | <1% | 1,188 | $55K | |
| J2704 | Injection, propofol, 10 mg | <1% | 4,629 | $53K |
| 80061 | Lipid panel | <1% | 1,499 | $52K |
| 81025 | <1% | 1,002 | $51K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,037 | $49K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 64 | $49K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,425 | $48K |
| 93971 | <1% | 280 | $46K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 71 | $43K |
| 89220 | <1% | 731 | $41K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,489 | $38K |
| 88342 | <1% | 204 | $36K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 285 | $31K |
| 82962 | <1% | 1,022 | $31K | |
| 76536 | <1% | 252 | $29K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,131 | $27K |
| G0378 | Hospital observation service, per hour | <1% | 192 | $26K |
| 47562 | <1% | 19 | $26K | |
| 87186 | <1% | 980 | $26K | |
| 87077 | <1% | 1,011 | $24K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 41 | $24K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 291 | $22K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,346 | $21K |
| 82803 | <1% | 360 | $21K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,205 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 940 | $18K |
| 73030 | <1% | 224 | $18K | |
| 43450 | <1% | 40 | $17K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,230 | $17K |
| 73630 | <1% | 205 | $17K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 100 | $16K |
| 73610 | <1% | 265 | $15K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 964 | $15K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 572 | $15K |
| 97161 | <1% | 169 | $14K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 254 | $13K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 298 | $13K |
| 36600 | <1% | 279 | $13K | |
| 80074 | <1% | 112 | $13K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 617 | $13K |
| 76981 | <1% | 110 | $12K | |
| 95806 | <1% | 110 | $12K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,508 | $12K |
| 73502 | <1% | 93 | $10K | |
| 87071 | <1% | 93 | $10K | |
| 73130 | <1% | 151 | $10K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 243 | $10K |
| 72131 | <1% | 29 | $10K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 26 | $10K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 935 | $9K |
| 85651 | <1% | 136 | $8K | |
| 95811 | <1% | 12 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 78 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 166 | $7K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 396 | $6K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 18 | $5K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 359 | $5K |
| 73562 | <1% | 72 | $5K | |
| 87205 | <1% | 98 | $5K | |
| 72110 | <1% | 73 | $4K | |
| 84436 | <1% | 116 | $4K | |
| 87522 | Neg quan hep c or qual rna | <1% | 16 | $4K |
| 80050 | General health panel | <1% | 31 | $4K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 227 | $4K |
| 80076 | <1% | 46 | $3K | |
| 82607 | <1% | 70 | $3K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 462 | $3K |
| 84439 | <1% | 91 | $3K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 290 | $3K |
| 73110 | <1% | 39 | $3K | |
| 74018 | <1% | 30 | $2K | |
| 83540 | <1% | 115 | $2K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 589 | $2K |
| 86756 | <1% | 29 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 78 | $2K |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | <1% | 13 | $1K |
| C1889 | Implantable/insertable device, not otherwise classified | <1% | 45 | $1K |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 62 | $1K |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 18 | $1K |
| 88304 | <1% | 28 | $1K | |
| 82140 | <1% | 13 | $1K | |
| 86140 | <1% | 35 | $810.94 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 123 | $610.12 |
| 83550 | <1% | 29 | $411.65 | |
| 82746 | <1% | 13 | $392.40 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 46 | $364.10 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 16 | $180.00 |
| 82977 | <1% | 13 | $128.71 | |
| 82248 | <1% | 15 | $99.28 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.